Sobi - Swedish Orphan Biovitrum AB (publ) Employee Directory
Pharmaceutical ManufacturingStockholm, Sweden1001-5000 Employees
Sobi is a global biopharmaceutical company focused on rare diseases, developing therapies to improve patients' daily lives. It traces its roots to Sweden and began as a pioneer in haemophilia, now operating with a worldwide reach. The company employs roughly 1,900 people and maintains a base in Stockholm, with operations spanning Europe, North America, the Middle East, Asia and Australia. Sobi is listed on Nasdaq Stockholm and positions itself as an innovative leader within the rare-disease field. In 2026, it was recognized among TIME and Statista's World's Most Impactful Companies, highlighting its broader impact.